Latest Revenue Growth News

oOh!media reports a 7% revenue increase in Q3 2025, slightly ahead of prior guidance, but flags challenges from a key New Zealand contract loss and softer advertising demand in October.

MedAdvisor Limited has appointed John Ciccio as its new CEO and Managing Director, marking a strategic leadership shift aimed at capitalising on recent technology advancements and US market growth.

Seven West Media reports a 6% EBITDA rise in H2 FY25 driven by TV and digital growth, while announcing a transformative merger with Southern Cross Media.

Light & Wonder, Inc. reported a 3% revenue increase for Q3 2025, driven by its Gaming and iGaming segments, alongside completing the Grover acquisition and refinancing debt with $1 billion in senior notes.

Coast Entertainment Holdings Limited reported its strongest financial performance since 2016, driven by robust ticket sales, new attractions, and a completed share buyback. The company enters FY26 with strong momentum amid strategic growth initiatives.

Cluey Ltd announces a strategic acquisition of tutoring provider Art of Smart, backed by a fully underwritten $4.5 million entitlement offer. The deal aims to expand Cluey’s omnichannel learning services and drive scalable growth.

National Australia Bank reported a 1% increase in underlying profit for FY25 with stable cash earnings and a steady fully franked dividend of 85 cents per share. The bank’s refreshed strategy shows early momentum despite rising credit impairment charges.

Verbrec Limited has agreed to acquire Alliance Automation for $5.5 million, significantly expanding its automation and digital capabilities while adding over $60 million in annual revenue.

4DMedical has responded to ASX queries over its FY2025 financial report, clarifying assumptions behind intangible asset valuations and addressing the auditor’s qualified opinion.

Stakk Limited has reported a record-breaking $575,000 in revenue for October 2025, marking a staggering 146% increase from the previous month and nearly 9,500% growth year-over-year.

ReNerve Limited is scaling up its clinical trial for the NervAlign® Nerve Cuff following promising interim results that show significant pain reduction in nerve repair patients. The expanded study aims to solidify evidence for broader regulatory approval and market adoption.

StepChange Holdings has officially entered the US market by establishing a Houston hub and securing an initial project with Woodside Energy, marking a significant step in its international growth strategy.